Resonea Funding: How Much Did They Raise & Key Investors

How Much Did Resonea Raise?
Funding & Key Investors

Resonea, a prominent player in the digital health sector, has successfully secured a significant capital injection, bringing its total funding to $348K. This latest infusion of $198K represents a major strategic investment that underscores the company's trajectory in the sleep health technology market. By leveraging this financial backing, the Scottsdale-based firm is well-positioned to accelerate its mission of democratizing access to sleep diagnostics through innovative mobile-first solutions.

The recent financing round highlights the growing investor confidence in Resonea's ability to disrupt traditional sleep medicine. As the company transitions through its late-stage growth phase, this capital will be instrumental in scaling its operations and expanding the reach of its proprietary diagnostic platforms.

What is Resonea?

Resonea

Hospitality

Gambling & Gaming

Established in 2016, Resonea, Inc. operates at the intersection of sleep science and mobile technology. The company is best known for its flagship product, DROWZLE PRO, which holds the distinction of being the first smartphone-based home sleep test cleared by the FDA. By utilizing advanced algorithms to detect obstructive sleep apnea, Resonea effectively removes the barriers associated with traditional, clinic-based sleep studies. This approach not only enhances patient safety by allowing for home-based testing but also significantly improves the scalability of sleep health services. Resonea's market position is defined by its commitment to improving performance, safety, and overall quality of life through accessible, data-driven health interventions.

How much funding has Resonea raised?

Resonea has raised a total of $348K across 2 funding rounds:

2020

Debt

$150K

2021

Debt

$198K

Debt (2020): $150K with participation from PPP

Debt (2021): $198K led by PPP

Key Investors in Resonea

PPP

Public-Private Partnership

What's next for Resonea?

With the recent influx of capital, Resonea is poised to deepen its market penetration and refine its diagnostic capabilities. The strategic focus will likely shift toward broader clinical adoption and the integration of its sleep health program into existing telehealth ecosystems. As the company continues to advance the science of sleep health, it remains focused on maintaining its regulatory edge and expanding its footprint in the digital therapeutics space. Future growth will be driven by the continued optimization of the DROWZLE platform and the potential for new partnerships with healthcare providers seeking to streamline patient care pathways for sleep-related disorders.

See full Resonea company page

See More Financial Insights